Global Ocular Drug Delivery Market Insights and Forecast to 2028

Report ID: 1154752 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Ocular Drug Delivery Product Introduction
    1.2 Market by Type
        1.2.1 Global Ocular Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Ocular Insert
        1.2.3 Iontophoresis
        1.2.4 Intraocular Implants
        1.2.5 In Situ Gel & Punctal Plugs
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Ocular Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Ophthalmic Clinics
        1.3.5 Homecare Settings
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Ocular Drug Delivery Sales Estimates and Forecasts 2017-2028
    2.2 Global Ocular Drug Delivery Revenue Estimates and Forecasts 2017-2028
    2.3 Global Ocular Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Ocular Drug Delivery Sales by Region
        2.4.1 Global Ocular Drug Delivery Sales by Region (2017-2022)
        2.4.2 Global Sales Ocular Drug Delivery by Region (2023-2028)
    2.5 Global Ocular Drug Delivery Revenue by Region
        2.5.1 Global Ocular Drug Delivery Revenue by Region (2017-2022)
        2.5.2 Global Ocular Drug Delivery Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Ocular Drug Delivery Sales by Manufacturers
        3.1.1 Global Top Ocular Drug Delivery Manufacturers by Sales (2017-2022)
        3.1.2 Global Ocular Drug Delivery Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ocular Drug Delivery in 2021
    3.2 Global Ocular Drug Delivery Revenue by Manufacturers
        3.2.1 Global Ocular Drug Delivery Revenue by Manufacturers (2017-2022)
        3.2.2 Global Ocular Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Revenue in 2021
    3.3 Global Ocular Drug Delivery Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Ocular Drug Delivery Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Ocular Drug Delivery Sales by Type
        4.1.1 Global Ocular Drug Delivery Historical Sales by Type (2017-2022)
        4.1.2 Global Ocular Drug Delivery Forecasted Sales by Type (2023-2028)
        4.1.3 Global Ocular Drug Delivery Sales Market Share by Type (2017-2028)
    4.2 Global Ocular Drug Delivery Revenue by Type
        4.2.1 Global Ocular Drug Delivery Historical Revenue by Type (2017-2022)
        4.2.2 Global Ocular Drug Delivery Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
    4.3 Global Ocular Drug Delivery Price by Type
        4.3.1 Global Ocular Drug Delivery Price by Type (2017-2022)
        4.3.2 Global Ocular Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Ocular Drug Delivery Sales by Application
        5.1.1 Global Ocular Drug Delivery Historical Sales by Application (2017-2022)
        5.1.2 Global Ocular Drug Delivery Forecasted Sales by Application (2023-2028)
        5.1.3 Global Ocular Drug Delivery Sales Market Share by Application (2017-2028)
    5.2 Global Ocular Drug Delivery Revenue by Application
        5.2.1 Global Ocular Drug Delivery Historical Revenue by Application (2017-2022)
        5.2.2 Global Ocular Drug Delivery Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
    5.3 Global Ocular Drug Delivery Price by Application
        5.3.1 Global Ocular Drug Delivery Price by Application (2017-2022)
        5.3.2 Global Ocular Drug Delivery Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Ocular Drug Delivery Market Size by Type
        6.1.1 North America Ocular Drug Delivery Sales by Type (2017-2028)
        6.1.2 North America Ocular Drug Delivery Revenue by Type (2017-2028)
    6.2 North America Ocular Drug Delivery Market Size by Application
        6.2.1 North America Ocular Drug Delivery Sales by Application (2017-2028)
        6.2.2 North America Ocular Drug Delivery Revenue by Application (2017-2028)
    6.3 North America Ocular Drug Delivery Market Size by Country
        6.3.1 North America Ocular Drug Delivery Sales by Country (2017-2028)
        6.3.2 North America Ocular Drug Delivery Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Ocular Drug Delivery Market Size by Type
        7.1.1 Europe Ocular Drug Delivery Sales by Type (2017-2028)
        7.1.2 Europe Ocular Drug Delivery Revenue by Type (2017-2028)
    7.2 Europe Ocular Drug Delivery Market Size by Application
        7.2.1 Europe Ocular Drug Delivery Sales by Application (2017-2028)
        7.2.2 Europe Ocular Drug Delivery Revenue by Application (2017-2028)
    7.3 Europe Ocular Drug Delivery Market Size by Country
        7.3.1 Europe Ocular Drug Delivery Sales by Country (2017-2028)
        7.3.2 Europe Ocular Drug Delivery Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Ocular Drug Delivery Market Size by Type
        8.1.1 Asia Pacific Ocular Drug Delivery Sales by Type (2017-2028)
        8.1.2 Asia Pacific Ocular Drug Delivery Revenue by Type (2017-2028)
    8.2 Asia Pacific Ocular Drug Delivery Market Size by Application
        8.2.1 Asia Pacific Ocular Drug Delivery Sales by Application (2017-2028)
        8.2.2 Asia Pacific Ocular Drug Delivery Revenue by Application (2017-2028)
    8.3 Asia Pacific Ocular Drug Delivery Market Size by Region
        8.3.1 Asia Pacific Ocular Drug Delivery Sales by Region (2017-2028)
        8.3.2 Asia Pacific Ocular Drug Delivery Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Ocular Drug Delivery Market Size by Type
        9.1.1 Latin America Ocular Drug Delivery Sales by Type (2017-2028)
        9.1.2 Latin America Ocular Drug Delivery Revenue by Type (2017-2028)
    9.2 Latin America Ocular Drug Delivery Market Size by Application
        9.2.1 Latin America Ocular Drug Delivery Sales by Application (2017-2028)
        9.2.2 Latin America Ocular Drug Delivery Revenue by Application (2017-2028)
    9.3 Latin America Ocular Drug Delivery Market Size by Country
        9.3.1 Latin America Ocular Drug Delivery Sales by Country (2017-2028)
        9.3.2 Latin America Ocular Drug Delivery Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Ocular Drug Delivery Market Size by Type
        10.1.1 Middle East and Africa Ocular Drug Delivery Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Ocular Drug Delivery Revenue by Type (2017-2028)
    10.2 Middle East and Africa Ocular Drug Delivery Market Size by Application
        10.2.1 Middle East and Africa Ocular Drug Delivery Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Ocular Drug Delivery Revenue by Application (2017-2028)
    10.3 Middle East and Africa Ocular Drug Delivery Market Size by Country
        10.3.1 Middle East and Africa Ocular Drug Delivery Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Ocular Drug Delivery Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 OCULAR THERAPEUTIX, INC
        11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
        11.1.2 OCULAR THERAPEUTIX, INC Overview
        11.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 OCULAR THERAPEUTIX, INC Recent Developments
    11.2 Alimera Sciences
        11.2.1 Alimera Sciences Corporation Information
        11.2.2 Alimera Sciences Overview
        11.2.3 Alimera Sciences Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Alimera Sciences Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Alimera Sciences Recent Developments
    11.3 Allergan, Plc
        11.3.1 Allergan, Plc Corporation Information
        11.3.2 Allergan, Plc Overview
        11.3.3 Allergan, Plc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Allergan, Plc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Allergan, Plc Recent Developments
    11.4 EyeGate Pharma
        11.4.1 EyeGate Pharma Corporation Information
        11.4.2 EyeGate Pharma Overview
        11.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 EyeGate Pharma Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 EyeGate Pharma Recent Developments
    11.5 Valeant Pharmaceuticals International, Inc
        11.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
        11.5.2 Valeant Pharmaceuticals International, Inc Overview
        11.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Valeant Pharmaceuticals International, Inc Recent Developments
    11.6 Envisia Therapeutics
        11.6.1 Envisia Therapeutics Corporation Information
        11.6.2 Envisia Therapeutics Overview
        11.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Envisia Therapeutics Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Envisia Therapeutics Recent Developments
    11.7 Clearside Biomedical
        11.7.1 Clearside Biomedical Corporation Information
        11.7.2 Clearside Biomedical Overview
        11.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Clearside Biomedical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Clearside Biomedical Recent Developments
    11.8 Graybug Vision Inc
        11.8.1 Graybug Vision Inc Corporation Information
        11.8.2 Graybug Vision Inc Overview
        11.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Graybug Vision Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Graybug Vision Inc Recent Developments
    11.9 Taiwan Liposome Company
        11.9.1 Taiwan Liposome Company Corporation Information
        11.9.2 Taiwan Liposome Company Overview
        11.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Taiwan Liposome Company Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Taiwan Liposome Company Recent Developments
    11.10 Santen Pharmaceutical
        11.10.1 Santen Pharmaceutical Corporation Information
        11.10.2 Santen Pharmaceutical Overview
        11.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Santen Pharmaceutical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Santen Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Ocular Drug Delivery Industry Chain Analysis
    12.2 Ocular Drug Delivery Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Ocular Drug Delivery Production Mode & Process
    12.4 Ocular Drug Delivery Sales and Marketing
        12.4.1 Ocular Drug Delivery Sales Channels
        12.4.2 Ocular Drug Delivery Distributors
    12.5 Ocular Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Ocular Drug Delivery Industry Trends
    13.2 Ocular Drug Delivery Market Drivers
    13.3 Ocular Drug Delivery Market Challenges
    13.4 Ocular Drug Delivery Market Restraints
14 Key Findings in The Global Ocular Drug Delivery Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Ocular Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Ocular Insert
    Table 3. Major Manufacturers of Iontophoresis
    Table 4. Major Manufacturers of Intraocular Implants
    Table 5. Major Manufacturers of In Situ Gel & Punctal Plugs
    Table 6. Major Manufacturers of Others
    Table 7. Global Ocular Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Ocular Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Ocular Drug Delivery Sales by Region (2017-2022) & (K Doses)
    Table 10. Global Ocular Drug Delivery Sales Market Share by Region (2017-2022)
    Table 11. Global Ocular Drug Delivery Sales by Region (2023-2028) & (K Doses)
    Table 12. Global Ocular Drug Delivery Sales Market Share by Region (2023-2028)
    Table 13. Global Ocular Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Ocular Drug Delivery Revenue Market Share by Region (2017-2022)
    Table 15. Global Ocular Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Ocular Drug Delivery Revenue Market Share by Region (2023-2028)
    Table 17. Global Ocular Drug Delivery Sales by Manufacturers (2017-2022) & (K Doses)
    Table 18. Global Ocular Drug Delivery Sales Share by Manufacturers (2017-2022)
    Table 19. Global Ocular Drug Delivery Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Ocular Drug Delivery Revenue Share by Manufacturers (2017-2022)
    Table 21. Ocular Drug Delivery Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 22. Global Ocular Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2021)
    Table 24. Ocular Drug Delivery Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Ocular Drug Delivery Product Offered
    Table 26. Date of Manufacturers Enter into Ocular Drug Delivery Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
    Table 29. Global Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
    Table 30. Global Ocular Drug Delivery Sales Share by Type (2017-2022)
    Table 31. Global Ocular Drug Delivery Sales Share by Type (2023-2028)
    Table 32. Global Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Ocular Drug Delivery Revenue Share by Type (2017-2022)
    Table 35. Global Ocular Drug Delivery Revenue Share by Type (2023-2028)
    Table 36. Ocular Drug Delivery Price by Type (2017-2022) & (USD/Dose)
    Table 37. Global Ocular Drug Delivery Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 38. Global Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
    Table 39. Global Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
    Table 40. Global Ocular Drug Delivery Sales Share by Application (2017-2022)
    Table 41. Global Ocular Drug Delivery Sales Share by Application (2023-2028)
    Table 42. Global Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Ocular Drug Delivery Revenue Share by Application (2017-2022)
    Table 45. Global Ocular Drug Delivery Revenue Share by Application (2023-2028)
    Table 46. Ocular Drug Delivery Price by Application (2017-2022) & (USD/Dose)
    Table 47. Global Ocular Drug Delivery Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 48. North America Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
    Table 49. North America Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
    Table 50. North America Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
    Table 53. North America Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
    Table 54. North America Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses)
    Table 57. North America Ocular Drug Delivery Sales by Country (2023-2028) & (K Doses)
    Table 58. North America Ocular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Ocular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
    Table 61. Europe Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
    Table 62. Europe Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
    Table 65. Europe Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
    Table 66. Europe Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses)
    Table 69. Europe Ocular Drug Delivery Sales by Country (2023-2028) & (K Doses)
    Table 70. Europe Ocular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Ocular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
    Table 73. Asia Pacific Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
    Table 74. Asia Pacific Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
    Table 77. Asia Pacific Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
    Table 78. Asia Pacific Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Ocular Drug Delivery Sales by Region (2017-2022) & (K Doses)
    Table 81. Asia Pacific Ocular Drug Delivery Sales by Region (2023-2028) & (K Doses)
    Table 82. Asia Pacific Ocular Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Ocular Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
    Table 85. Latin America Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
    Table 86. Latin America Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
    Table 89. Latin America Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
    Table 90. Latin America Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses)
    Table 93. Latin America Ocular Drug Delivery Sales by Country (2023-2028) & (K Doses)
    Table 94. Latin America Ocular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Ocular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
    Table 97. Middle East and Africa Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
    Table 98. Middle East and Africa Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
    Table 101. Middle East and Africa Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
    Table 102. Middle East and Africa Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses)
    Table 105. Middle East and Africa Ocular Drug Delivery Sales by Country (2023-2028) & (K Doses)
    Table 106. Middle East and Africa Ocular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Ocular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 108. OCULAR THERAPEUTIX, INC Corporation Information
    Table 109. OCULAR THERAPEUTIX, INC Description and Major Businesses
    Table 110. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 111. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. OCULAR THERAPEUTIX, INC Recent Developments
    Table 113. Alimera Sciences Corporation Information
    Table 114. Alimera Sciences Description and Major Businesses
    Table 115. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 116. Alimera Sciences Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Alimera Sciences Recent Developments
    Table 118. Allergan, Plc Corporation Information
    Table 119. Allergan, Plc Description and Major Businesses
    Table 120. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 121. Allergan, Plc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Allergan, Plc Recent Developments
    Table 123. EyeGate Pharma Corporation Information
    Table 124. EyeGate Pharma Description and Major Businesses
    Table 125. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 126. EyeGate Pharma Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. EyeGate Pharma Recent Developments
    Table 128. Valeant Pharmaceuticals International, Inc Corporation Information
    Table 129. Valeant Pharmaceuticals International, Inc Description and Major Businesses
    Table 130. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 131. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Valeant Pharmaceuticals International, Inc Recent Developments
    Table 133. Envisia Therapeutics Corporation Information
    Table 134. Envisia Therapeutics Description and Major Businesses
    Table 135. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 136. Envisia Therapeutics Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Envisia Therapeutics Recent Developments
    Table 138. Clearside Biomedical Corporation Information
    Table 139. Clearside Biomedical Description and Major Businesses
    Table 140. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 141. Clearside Biomedical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Clearside Biomedical Recent Developments
    Table 143. Graybug Vision Inc Corporation Information
    Table 144. Graybug Vision Inc Description and Major Businesses
    Table 145. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 146. Graybug Vision Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Graybug Vision Inc Recent Developments
    Table 148. Taiwan Liposome Company Corporation Information
    Table 149. Taiwan Liposome Company Description and Major Businesses
    Table 150. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 151. Taiwan Liposome Company Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Taiwan Liposome Company Recent Developments
    Table 153. Santen Pharmaceutical Corporation Information
    Table 154. Santen Pharmaceutical Description and Major Businesses
    Table 155. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 156. Santen Pharmaceutical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Santen Pharmaceutical Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Ocular Drug Delivery Distributors List
    Table 161. Ocular Drug Delivery Customers List
    Table 162. Ocular Drug Delivery Market Trends
    Table 163. Ocular Drug Delivery Market Drivers
    Table 164. Ocular Drug Delivery Market Challenges
    Table 165. Ocular Drug Delivery Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ocular Drug Delivery Product Picture
    Figure 3. Global Ocular Drug Delivery Market Share by Type in 2021 & 2028
    Figure 3. Ocular Insert Product Picture
    Figure 4. Iontophoresis Product Picture
    Figure 5. Intraocular Implants Product Picture
    Figure 6. In Situ Gel & Punctal Plugs Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Ocular Drug Delivery Market Share by Application in 2021 & 2028
    Figure 9. Hospitals
    Figure 10. Ambulatory Surgical Centers
    Figure 11. Ophthalmic Clinics
    Figure 12. Homecare Settings
    Figure 13. Ocular Drug Delivery Report Years Considered
    Figure 14. Global Ocular Drug Delivery Sales 2017-2028 (K Doses)
    Figure 15. Global Ocular Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Ocular Drug Delivery Revenue 2017-2028 (US$ Million)
    Figure 17. Global Ocular Drug Delivery Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Ocular Drug Delivery Sales Market Share by Region (2017-2022)
    Figure 19. Global Ocular Drug Delivery Sales Market Share by Region (2023-2028)
    Figure 20. North America Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
    Figure 21. North America Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
    Figure 23. Europe Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
    Figure 25. Asia-Pacific Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
    Figure 27. Latin America Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
    Figure 29. Middle East & Africa Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Ocular Drug Delivery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Ocular Drug Delivery in the World: Market Share by Ocular Drug Delivery Revenue in 2021
    Figure 32. Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Ocular Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 34. Global Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 35. Global Ocular Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 36. Global Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 37. North America Ocular Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 38. North America Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 39. North America Ocular Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 40. North America Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 41. North America Ocular Drug Delivery Sales Share by Country (2017-2028)
    Figure 42. North America Ocular Drug Delivery Revenue Share by Country (2017-2028)
    Figure 43. U.S. Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Ocular Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 46. Europe Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Ocular Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 48. Europe Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Ocular Drug Delivery Sales Share by Country (2017-2028)
    Figure 50. Europe Ocular Drug Delivery Revenue Share by Country (2017-2028)
    Figure 51. Germany Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 52. France Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Ocular Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Ocular Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Ocular Drug Delivery Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Ocular Drug Delivery Revenue Share by Region (2017-2028)
    Figure 62. China Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 65. India Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Ocular Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Ocular Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Ocular Drug Delivery Sales Share by Country (2017-2028)
    Figure 77. Latin America Ocular Drug Delivery Revenue Share by Country (2017-2028)
    Figure 78. Mexico Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Ocular Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Ocular Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Ocular Drug Delivery Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Ocular Drug Delivery Revenue Share by Country (2017-2028)
    Figure 87. Turkey Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 90. Ocular Drug Delivery Value Chain
    Figure 91. Ocular Drug Delivery Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Frequently Asked Questions
Ocular Drug Delivery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ocular Drug Delivery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ocular Drug Delivery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Flatting Agents

Flatting Agents market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More